Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Dixon Investments Inc
FDA Inspection
•Dixon Investments Inc•March 11, 2025

Dixon Investments Inc – FDA Inspection, Mar 11, 2025

Record Details

This FDA Inspection record concerns Dixon Investments Inc, with an inspection on March 11, 2025, issued by the Atlanta District Office, covering human drugs.

Company
Dixon Investments Inc
Inspection Date
March 11, 2025
Product Type
Human Drugs
Office
Atlanta District Office
Person
  • Samantha E. Cleek (Investigator)
View Company Profile

ID · 91961a19-5a06-4d00-8690-898dde318914

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1263416
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued, view the record

FDA Citations

7
  1. 21 CFR 211.166(b)Adequate number of batches on stability
  2. 21 CFR 211.68(b)Computer control of master formula records
  3. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  4. 21 CFR 211.25(a)GMP Training Frequency
  5. 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
  6. 21 CFR 211.22(d)Procedures not in writing, fully followed
  7. 21 CFR 211.180(e)(1)Review of representative number of batches

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Dixon Investments Inc

5
DateClassificationOfficeProject area
March 22, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 16, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 6, 2013VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 13, 2011VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 25, 2010VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Dixon Investments Inc
  • FDA Inspection 1083739 - 2019-03-22
  • FDA Inspection 956550 - 2015-12-16
  • FDA Inspection 858354 - 2013-12-06
  • FDA Inspection 758691 - 2011-12-13
  • FDA Inspection 646629 - 2010-01-25

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dixon Investments Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.